All News

2058 articles, sorted by publication time.

New Cancer Drugs · global

Petosemtamab Plus Immunotherapy Meets Phase 3 Endpoints, Reduces Risk of Death by 50% in Head and Neck Cancer

In patients with PD-L1-positive recurrent or metastatic head and neck cancer, a bispecific antibody combined with pembrolizumab improved both overall survival and tumor response. The first interim analysis provides new evidence, but full data are still needed to determine how much longer patients live and the extent of the treatment burden.

Immunology and Transplant Medicine · us

Where do gut-damaging T cells go after transplantation? Single-cell study traces persistent expansion and tissue adaptation

Following 31 hematopoietic stem cell transplant recipients, researchers linked changes in blood T cells to intestinal lesions: cells associated with severe disease continued to expand, changed state after entering tissue, and clustered in regions containing intestinal stem cells. These clues may help identify risk, but have not yet become a prediction tool for clinical use.